To elucidate the mechanism of 17-␤ estradiol (17␤-E 2 )-mediated protection of retinal pigment epithelium (RPE) from oxidative stress. METHODS. Cultured ARPE-19 cells were subjected to oxidative stress with t-butyl hydroxide or hydrogen peroxide in the presence or absence of 17␤-E 2 . Reactive oxygen species (ROS) were measured using H 2 DCFDA fluorescence. Apoptosis was evaluated by cell-death ELISA kit and Hoechst-3486 staining. Mitochondrial membrane potential was measured using the JC-1 assay. Cellular localization of estrogen receptor (ER) was evaluated by confocal microscopy. Gene expression and protein expression was quantified using qRT-PCR and western blotting. Superoxide dismutase and ATP levels were measured using commercial kits. RESULTS. ARPE-19 cells expressed significant amounts of ER␣ and ER␤. Pretreatment with 17␤-E2 protected ARPE-19 cells from oxidative stress and apoptosis. 17␤-E 2 reduced the ROS levels and mitochondrial depolarization. The 17␤-E 2 -mediated cytoprotection was inhibited by ER antagonists ICI (ER␣ and ER␤) and THC (ER␤) but not by tamoxifen (ER␣). Knockdown of ER␤ expression by siRNA abolished the protective effects of 17␤-E 2 . Further, qRT-PCR analysis revealed that 17␤-E 2 pretreatment upregulated the expression of ER␤ and phase II cellular antioxidant genes. CONCLUSIONS. These results indicate that 17␤-E 2 protects ARPE-19 cells from oxidative stress through an ER␤-dependent mechanism. 17␤-E 2 -mediated cytoprotection occurred through the preservation of mitochondrial function, reduction of ROS production, and induction of cellular antioxidant genes. (Invest Ophthalmol Vis Sci.
A ge related macular degeneration (AMD) is the leading cause of blindness among the elderly population in the Western world. 1, 2 The number of patients with AMD is expected to increase from 1.75 million to 3 million in the next decade. 3 Epidemiologic studies suggest a strong association between estrogen deficiency, early menopause, and the development of AMD in women. 4 -7 The pathogenesis of AMD involves apoptosis of the retinal pigment epithelium (RPE) followed by death of the underlying photoreceptors. 8, 9 Because of its unique location and function, the RPE provides an ideal environment for the accumulation of reactive oxygen intermediates (ROIs), 10 which, in turn, leads to mitochondrial dysfunction and RPE death. 11 Although antioxidants such as ␤-carotene, zinc, and vitamins C and E have been shown to slow the progression of this disease, 12, 13 there is no effective treatment for advanced atrophic AMD.
Several in vitro and in vivo studies have shown that 17␤-estradiol (17␤-E 2 ) protects RPE from oxidative stress. 14 -16 Microarray analysis of RPE exposed to hydrogen peroxide (H 2 O 2 ) showed that 17␤-E 2 pretreatment induced the upregulation of apoptosis-related protein and protected the RPE from degeneration. 15 Estrogen deficiency in high-fat fed C57BL/6 mice increased the severity of sub-RPE deposits. 16 Estrogens have been shown to protect a variety of tissues, including brain, breast, myocardium, and lens epithelium, from oxidative damage by targeting the mitochondrial respiratory chain. 17 Despite these compelling observations, the mechanism by which the estrogens protect cells from oxidative stress is not completely understood. Some studies suggest an ER-mediated mechanism, 18, 19 whereas others suggest that estrogens act as general antioxidants. 20 In this study, we set out to investigate the mechanism of 17␤-E 2 -mediated cytoprotection in RPE cells and to identify the ER subtype that mediates these protective effects. We used the well-characterized model of H 2 O 2 -induced oxidative stress in ARPE-19 cells as the in vitro model system. This study provides the first definitive evidence that activation of ER␤ protects RPE from oxidative stress, which is hypothesized to play a role in pathogenesis of AMD.
MATERIALS AND METHODS

Reagents
Dulbecco's modified Eagle's medium (DMEM/ F12) was obtained from Hyclone (Logan, UT). Phosphate-buffered saline (PBS containing Ca 2ϩ and Mg 2ϩ ), 1 M Tris, pH 8.0, and 0.5 M EDTA were obtained from Mediatech (Manassas, VA). Probe (MitoTracker; M7512) and 2Ј, 7Ј-dichlorodihydrofluorescein (H 2 DCFDA) were obtained from Molecular Probes (Eugene, OR). H 2 O 2 and t-butyl hydroxide (t-BH) were obtained from Fisher Scientific (Pittsburgh, PA); 17␣-E 2 and 17␤-E 2 were obtained from Sigma Aldrich (St. Louis, MO). Tamoxifen, ICI-182780 (ICI), and tetrahydrochrysene (THC) were purchased from Tocris (Ellisville, MO). Charcoal stripped/dextran-treated fetal bovine serum (csFBS) was obtained from Atlanta Biologicals (Lawrenceville, GA). 
Measurement of Necrosis and Apoptosis
Measurement of ATP Levels
ARPE-19 cells were treated with vehicle or 17␤-E 2 and then exposed to 500 M H 2 O 2 for 4 hours. Cells were washed with PBS, trypsinized, and pelleted at 250g for 5 minutes. Approximately 5 ϫ 10 4 cells were lysed with 1 mL HBSS containing 0.5% TCA and 4 mM EDTA. The lysate was then centrifuged at 3000g for 10 minutes, and the supernatants were taken for analysis. The pH of samples was adjusted to approximately 7.75 using 25 mM Tris (pH 8.0). An aliquot (25 L) of the sample was loaded on a 96-well plate to measure intracellular ATP levels using an assay kit (ENLITEN ATP Assay kit; Promega, Madison, WI) in accordance with the manufacturer's instructions.
Measurement of Superoxide Dismutase Activity
ARPE-19 cells (4 ϫ 10 6 cells in 15-cm plates) were incubated with 17␤-E 2 or vehicle and then treated with 1 mM H 2 O 2 for 24 hours. After the incubation period, mitochondrial and cytosolic fractions were extracted using a mitochondria isolation kit (Pierce, Rockford, IL) in accordance with the manufacturer's instructions. Superoxide dismutase (SOD) activity in the fractions was determined using a SOD assay kit (Assay Designs, Ann Arbor, MI) in accordance with the manufacturer's instructions. 
Real-Time Quantitative PCR
Western Blot Analysis
ARPE-19 cell lysates were obtained at 4, 8, 12 , and 24 hours after exposure to 1 mM H 2 O 2 . The lysates were centrifuged at 3000g for 5 minutes, and the supernatants were resolved on a 5% to 20% SDS-PAGE gradient gel (Bio-Rad, Hercules, CA). The nuclear/mitochondrial/cytosolic-enriched fractions were separated in accordance with the manufacturer's instructions in the mitochondria isolation kit (Pierce, Rockford, IL). Proteins were transferred to nitrocellulose membranes, and immunoblotting was performed with antibodies to mouse anti-ER␣, rabbit anti-ER␤, and mouse anti-␤-actin. Immunodetection was performed with secondary antibody conjugated to HRP and an enhanced chemiluminescence kit (Amersham, Piscataway, NJ). Densitometry was performed using image editing software (Photoshop CS4; Adobe Systems Incorporated, San Jose, CA). 
Immunohistochemistry and Confocal Microscopy
ARPE-19 cells (3 ϫ 10 4 cells/well) on a four-well chamber slide (LabTek, Scotts Valley, CA) were treated with vehicle or 17␤-E 2 and then exposed to 500 M H 2 O 2 for 4 hours. The cells were washed with PBS and incubated with 100 nM probe (MitoTracker; Molecular Probes) at 37°C for 20 minutes. The cells were then fixed with 4% paraformaldehyde for 15 minutes and blocked with buffer (10% normal goat serum, 5% BSA, 0.02% Triton X-100 in PBS) for 60 minutes. The cells were incubated in rabbit anti-ER␤ (H-150) (1:200) overnight at 4°C. After the incubation period, the slides were washed with PBS and incubated in secondary antibody (goat anti rabbit Alexa-488; 1:300) and nuclear stain (ToPro-3, 1:300; Molecular Probes, CA) for 60 minutes at room temperature. Slides were mounted with mounting medium (Vectashield; Vector Laboratories, Burlingame, CA).
Small Interfering RNA Knockdown of ER␤
To knockdown ER␤ gene expression from ARPE-19 cells, we used Accell smart pool small interfering RNA (siRNA; mixture of 4 siRNA duplexes; Dharmacon, Inc., Chicago, IL) against ER␤ (cat. no. E-003402-00-0010) or ER␣ (cat. no. E-00341-00-0002) or GAPDH or nontargeting siRNA. Cells were transfected with 1 M siRNA in siRNA delivery medium (Accell; Dharmacon, Inc.) for 72 hours at 37°C. After the incubation period, ER protein expression was determined in cell lysates by Western blot analysis. Cells in siRNAcontaining medium were then used in the JC-1 assay to measure mitochondrial protection.
RESULTS
Western Blot Analysis for Estrogen Receptor Expression
We first compared the expression of ER␣ and ER␤ in primary hRPE with that observed in ARPE-19 cells. The primary RPE cells were obtained from both male (hRPE-8, hRPE-12, hRPE-14, hRPE-15) and female (hRPE-13) patients (age range, 41-72 years). Western blot analysis of the cell lysates showed that both hRPE cells and ARPE-19 cells express high levels of ER␣ and ER␤ (Fig. 1 ). ER␤ expression levels were similar in all cell lines examined (Fig. 1B) . ER␣ expression was more variable with hRPE 13 from a female donor (ϳ43 years) with the most ER␣ expression (Fig. 1C) . Because there was no significant difference in ER␤ expression between the hRPE and ARPE-19 cells, all our subsequent experiments were carried out using the well-characterized ARPE-19 cells.
Oxidative Stress Assay Conditions
We performed dose-response studies with membrane-permeable oxidants H 2 O 2 and t-BH to determine the LC 50 for each oxidant. Treatment with H 2 O 2 (concentrations up to 1 mM) induced ROS formation, but the magnitude of ROS accumulation was lower than that seen with t-BH ( Figs. 2A, 2B ). The LC 50 was found to be dependent on the confluence of the cultures. The LC 50 for subconfluent monolayers was approximately 500 M H 2 O 2 and approximately 150 M t-BH (Figs. 2A,  2B ), whereas in confluent monolayers the LC 50 was 1 mM for H 2 O 2 and 300 M for t-BH, respectively (data not shown). Data presented in this study are from H 2 O 2 -induced stress experiments unless specifically stated.
Intracellular Reactive Oxygen Species Accumulation
Treatment of ARPE cells with t-BH (150 M) increased the intracellular accumulation of ROS (Fig. 2C ) compared with untreated cells. 17␤-E 2 attenuated the ROS accumulation in a concentration-dependent manner with maximal effect seen at 1 M concentration (data not shown). This concentration of 17␤-E 2 was used for all subsequent experiments. At 1 M concentration, 17␤-E 2 limited ROS accumulation in the cells by 53% compared with t-BH-only controls (Fig. 2C) . Pretreatment with ER antagonist ICI reversed the protective effects of 17␤-E 2 . 
Oxidative Stress-Induced Cell Death
To evaluate the effects of oxidative stress on cell growth, we monitored ARPE-19 cells for changes in morphology, apoptosis, and necrosis 24 hours after exposure to 500 M H 2 O 2 . After 24-hour exposure, a significant number of cells showed cell rounding and detached from the plate (Fig. 3A) . Nuclear staining (Hoechst-33342) of the cells revealed pyknotic nuclei (Fig. 3A, arrowheads) indicating condensed chromatin (bright punctate labeling) and apoptosis. A significant number of cells (ϳ25%) underwent necrosis ( Table 2 ). Pretreatment with 17␤-E 2 reduced the percentage of necrotic cells to 11.98% Ϯ 4.3% (Table 2) . ARPE-19 cells exposed to peroxide had a fivefold increase in apoptosis relative to untreated cells (Fig.  3B) . Pretreatment with 17␤-E 2 before H 2 O 2 exposure reduced the percentage of apoptotic cells to 41% Ϯ 6.79% (Fig. 3B) . Further, the morphology of the 17␤-E 2 -pretreated cells was similar to that of the untreated controls (Fig. 3A) indicating cytoprotection. This protective effect was abolished on pretreatment with ER antagonist ICI, suggesting an ER-dependent mechanism for the action of 17␤-E 2 (Fig. 3B) .
Oxidative Stress Affects Mitochondrial Function
Mitochondrial Membrane Potential. H 2 O 2 caused a rapid loss of mitochondrial membrane potential as seen by the increase in the green/red fluorescence ratio (Figs. 4A, 4B ). Pretreatment with 17␤-E 2 reduced mitochondrial depolarization in a dose-dependent manner, with the maximum (ϳ50%) reduction seen at 1 M concentration compared with H 2 O 2 -only treated cells (Figs. 4A, 4B ). This protective effect of 17␤-E 2 was also prevented by ICI (Fig. 4B) . Intracellular ATP Levels. H 2 O 2 depleted intracellular ATP levels by 80% compared with that of the control untreated cells (Fig. 5A) . Pretreatment with 17␤-E 2 limited ATP loss to just 30% compared with the controls.
Superoxide Dismutase Levels in Cells. H 2 O 2 stress reduced cytosolic (63% Ϯ 2.2%) and mitochondrial SOD (45.10% Ϯ 2.45%) activity compared with control untreated cells (Fig. 5B) . Pretreatment with 17␤-E 2 partially prevented decreases in mitochondrial (76.17% Ϯ 2.98%) and cytosolic SOD (71.60% Ϯ 2.34%) levels compared with H 2 O 2 -treated cells.
Role of ER␤ in 17␤-E 2 -Mediated Protection: Mechanisms
Effect of Non-ER Binding Ligand. To determine whether ER binding is required for mitochondrial protection from H 2 O 2 stress, we used 17␣-E 2 (a structural analog of 17␤-E 2 , which binds ER with 100-fold less potency). Pretreatment with 17␣-E 2 protected only a small percentage of cells (17.38% Ϯ 3.07%) from membrane depolarization compared to 17␤-E 2 treatment (48.5% Ϯ 3.07%: Fig. 6A) .
Effect of ER Inhibitors. We performed the JC-1 assay in the presence of ER inhibitors ICI (pure ␣ and ␤ antagonists), tamoxifen (ER␣ partial agonist/antagonist) and THC (pure ER␤ antagonist). The antagonists had no effect on loss of mitochondrial membrane potential mediated by H 2 O 2 (data not shown). Preincubation of cells with ICI or THC before 17␤-E 2 treatment completely abrogated the protective effects of 17␤-E 2 (Fig. 6A) . In contrast, tamoxifen did not reverse the protective effect of 17␤-E 2 ( Fig. 6A) but did prevent the moderate protection mediated by 17␣-E 2 .
Effect of ER␤ Knockdown. To evaluate the role of ER␤ in mitochondrial protection, we performed siRNA-mediated silencing of gene expression. Western blot analysis 72 hours after transfection with the siRNA duplexes specific to ER␤ revealed a knockdown of ER␤ expression (Fig. 6B, lane 5) . No change in ER␤ expression was seen when cells were transfected with nontarget siRNA (Fig. 6B, lanes 2-4) . When siRNA-transfected cells were subjected to H 2 O 2 stress and JC-1 assay was performed, 17␤-E 2 prevented the loss of mitochondrial potential induced by H 2 O 2 in cells transfected with scrambled or ER␣ siRNA or GAPDH siRNA (Fig. 6C) (A) Dose-response data. Mitochondrial membrane potential was measured using JC-1 dye. ARPE-19 cells in serum-free medium were pretreated with vehicle or increasing concentrations of 17␤-E 2 and then exposed to 500 M H 2 O 2 for 4 hours. (B) 17␤-E 2 protects mitochondria in an ER-dependent manner. ARPE-19 cells in serum-free medium were pretreated with vehicle or 1 M 17␤-E 2 , 1 M ICI, or 1 M 17␤-E 2 ϩ ICI and were exposed to 500 M H 2 O 2 for 4 hours and then stained with JC-1 dye. Mitochondrial membrane potential was calculated as a ratio of green to red fluorescence and is expressed as a percentage of H 2 O 2 -only treated cells. For all experiments, n ϭ 3; mean Ϯ SEM; **P Ͻ 0.01 and ***P Ͻ 0.001 versus oxidant-only treated cell. was seen to colocalize within the collapsed mitochondria (intense yellow tubular structures in the perinuclear region; Figs. 7C, 7CЈ, arrowheads). In cells pretreated with 17␤-E 2 followed by H 2 O 2 treatment, there was a significant increase in ER␤ staining in mitochondria (Figs. 7D, 7DЈ ) compared with H 2 O 2 -only treated cells. In addition, we performed subcellular fractionation of the cells at 4 hours after oxidative stress and analyzed ER␤ protein levels in cytosol, mitochondria, and nucleus. Our results show that oxidative stress reduced mitochondrial and nuclear pools of ER␤ whereas the cytosolic pool was increased (Fig. 7E) . Pretreatment with 17␤-E 2 restored the nuclear and mitochondrial ER␤ pools (Fig. 7E) .
ER␤-Induced Gene Expression
Pretreatment with 17␤-E 2 before H 2 O 2 stress increased ER␤ gene expression by 4.3-fold compared with controls. Pretreatment with ICI before exposure to 17␤-E 2 prevented the up-FIGURE 5. (A) Cellular ATP levels were measured using a luciferin-luciferase-based assay. Cells were exposed to H 2 O 2 with or without 17␤-E 2 pretreatment, and ATP levels were measured at 4 hours after oxidative stress. The total amount of ATP in each sample was determined as RLU U/mol ATP. Results are expressed as a percentage of ATP in untreated ARPE-19 cells (control). (B) SOD activity was determined using a colorimetric assay. Mitochondrial and cytosolic fractions were isolated by differential centrifugation of cell lysates at 24 hours, and the levels of SOD in each fraction was estimated using a commercial kit. SOD levels are expressed as a percentage of enzyme activity in untreated ARPE-19 cells (control). For all experiments, n ϭ 3; mean Ϯ SEM; ***P Ͻ 0.001 versus oxidant-only treated cell. To distinguish cellular compartments, mitochondria were labeled with probe (MitoTracker; red) and the nuclei were stained with nuclear stain (ToPro; blue). ER␤ protein expression was detected using polyclonal rabbit anti-ER␤ (H-150) antibody and counterstained with anti-rabbit Alexa-488 antibody (green). Images were acquired with a confocal microscope using multitrack configuration. All images were acquired on the same day using the same parameters and were uniformly processed. Representative images at 40ϫ magnification from cells treated with vehicle (A, AЈ), 1 M 17␤-E 2 only (B, BЈ), 500 M H 2 O 2 (C, CЈ), and 500 M H 2 O 2 ϩ 1 M 17␤-E2 (D, DЈ) are shown in all three separate channels. Right: overlay of all three channels to show colocalization. Arrows: normal punctate colocalization of ER␤ in the mitochondria located in the perinuclear region. Arrowheads: ER␤ colocalization along the collapsed mitochondria. AЈ-DЈ represent 2.5ϫ digital magnification of the overlay images. (E) Western blot of ER␤: cytosolic, mitochondrial, and nuclear-enriched fractions were obtained at 4 hours after oxidative stress and probed for the presence of ER␤. ␤-Actin (cytosolic marker), VDAC (mitochondrial marker), and RNA polymerase II (nuclear marker).
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IOVS, October 2010, Vol. 51, No. 10 regulation of ER␤ gene expression (Fig. 8A) . Western blot analysis for ER␤ showed that protein levels increased by 8 hours after stress and were reduced to baseline by 24 hours (Fig. 8B) . Treatment with 17␤-E 2 without oxidative stress had no effect on the protein levels of ER␤ (Fig. 8C) . On the other hand, ER␣ gene expression was downregulated with H 2 O 2 stress, and 17␤-E 2 or ICI pretreatment had no beneficial effects on gene expression (Fig. 8A ). H 2 O 2 stress downregulated gene expression of GPx2 (Ϫ4.25-fold) and HO-1 (Ϫ0.52-fold) compared with vehicletreated cells (Fig. 8A) . When the cells were pretreated with 17␤-E 2 before oxidative stress, there was an upregulation of HO-1 expression (2.5-fold), whereas GPx2 level was brought back to that of vehicle-treated cells (Fig. 8A) . Induction of the phase II genes was completely abolished on treatment with the ER antagonist ICI. No change in the expression of HO-2 (constitutive form of HO) or GPx3 was observed with any treatments.
DISCUSSION
In these studies we showed that 17␤-E 2 at pharmacologic concentrations prevented the accumulation of ROS, collapse of mitochondrial potential, loss of cellular ATP, and apoptosis of the RPE cells caused by oxidative stress. We also showed that the protection of mitochondria by 17␤-E 2 is ER dependent because the ER antagonist (ICI 182170) blocks the beneficial effects. ICI is a pure antagonist of ER and leads to the degradation of ER receptors. 22 Therefore, we infer that the lack of protective effect in the presence of ICI is due to the lack of ER in the cells after treatment. Additionally 17␣-E 2 , a weak ER␣ ligand, provided only marginal protection compared with 17␤-E 2, indicating a requirement for tight binding with the receptor. These data indicate that 17␤-E 2 protects mitochondria in ARPE-19 cells through a specific receptor-mediated mechanism. Several reports have shown that estrogens protect mitochondria in human lens epithelial cells (HLECs) from H 2 O 2 death. 20, 23, 24 The molecular mechanism of protection in HLECs was a rapid nongenomic-type response and was ER dependent.
Estrogens mediate their physiological effects through two subtypes of receptors, ER␣ and ER␤. These are nuclear receptors that, on ligand binding, translocate to the nucleus and modulate gene expression. 25 Although few studies suggest that ER␤ acts as a negative regulator of ER␣, 26, 27 the role of ER␤ in cellular physiology is not clearly understood. 〉oth ER subtypes are expressed in the male and female retina. 28, 29 Similar to these studies, our RNA and protein expression results confirmed that ER␣ and ER␤ are expressed in the RPE. To identify which of the ER subtypes is required for protecting RPE from oxidative stress, we used ER subtype-specific antagonists and targeted knockdown of ER gene expression. Our results show that antagonists that block ER␤ (ICI or THC) completely abrogated the beneficial effects of 17␤-E 2 . Preincubation with tamoxifen (ER␣ antagonist) reversed the effect of 17␣-E2 (ER␣ agonist) but did not block 17␤-E 2 -mediated cytoprotection. Barkhem et al. 30 showed that 17␣-E2 has partial agonism in 293/hER␤ cells and full agonist activity in 293/hER␣ cells. These results indicate that the mild protection seen with 17␣-E2 is probably an ER␣-mediated effect. Further, siRNA knockdown of ER␤ gene expression, but not ER␣ gene expression, resulted in the loss of mitochondrial potential even in the presence of 17␤-E 2 . These data indicate that 17␤-E 2 mediates its protection by engaging ER␤ but not ER␣. This is the first report to elucidate the role of ER␤ in protecting mitochondria in RPE cells from oxidative damage. Previously, it had been demonstrated that ER␤ plays an important role in regulating extracellular matrix turnover during oxidant injury in RPE both in vitro and in vivo. 14, 31 These observations indicate that ER␤ can protect RPE from oxidative stress through multiple mechanisms.
ER␤ was shown to localize to the mitochondria of HLECS and protect the cells from oxidative stress. 24 In RPE cells, unliganded ER␤ was distributed in the cytoplasm, nuclei, and mitochondria, similar to the localization of the wild-type receptor in HLECs. 24 During oxidative stress, the receptor predominantly colocalized with the collapsed mitochondria in the perinuclear region. In cells pretreated with 17␤-E 2, mitochondrial membrane potential was preserved and there was increased ER␤ receptor colocalization with the mitochondria as early as 4 hours. At this time point, there was a fourfold increase in transcript levels of ER␤, but protein levels were increased only 8 hours after exposure. These data, along with our subcellular fractionation results (Fig. 7E) , indicate that at the earlier time points, 17␤-E 2 may stabilize the mitochondrial ER␤ levels or induce translocation of ER␤ to the mitochondria. Although the exact mechanism by which mitochondria-associated ER␤ protects RPE cells from oxidative stress is unknown, we speculate that ER␤ and possibly estrogen bound to the receptor associate with the mitochondrial permeability transition pore and stabilize the mitochondrial membrane, similar to that suggested for HLECs. 24 Estrogens, estrogen metabolites, and phytoestrogens have been reported to induce phase II detoxification enzymes in myocardial cells, 32 IMR-32 cells, 33 and HepG2 cells. 34 Phase II proteins such as HO-1 and GPx neutralize the reactive oxygen species and protect the cells from oxidative injury. These proteins provide cells with the ability to mount a prolonged and sustained defense against the deleterious effect of oxidants such as superoxide and H 2 O 2 . In our study, 17␤-E 2 upregulated HO-1 and GPx2 gene expression in H 2 O 2 -stressed cells, and this induction was inhibited by ER antagonist ICI, indicating a receptor-mediated regulation of gene expression. Previous studies have shown both ER-dependent and -independent mechanisms for HO-1 expression. In H9c2 myocardial cells 32 and HepG2 cells, 34 the expression of phase II genes was ER dependent, but in IMR-32 cells, 33 the ER was not required for phase II gene expression.
Apart from the effect on phase II genes, we also show that 17␤-E 2 modulates intracellular levels of SOD. SOD is an enzyme that is involved in the cellular defense against oxidative stress by detoxification of ROS. SOD has three isoforms, cytosolic Cu/Zn SOD (Cu/ZnSOD), mitochondrial manganese SOD (MnSOD), and extracellular SOD (ecSOD). Reduction in MnSOD levels is associated with disruption of mitochondrial function, accelerated DNA strand breakage, and precocious neuronal degeneration. 35 In our study, H 2 O 2 stress reduced the levels of the mitochondrial MnSOD by more than 50%, indicating that this could be a contributing factor to mitochondrial dysfunction. 17␤-E 2 treatment significantly alleviated the loss of MnSOD and of Cu/Zn SOD in H 2 O 2 -treated cells, indicating an additional role for estrogens in maintaining cellular antioxidant function.
In summary, our data suggest that activation of ER␤ protects RPE cells from oxidative damage in two phases, a quick or immediate phase that involves rapid translocation of ligandreceptor complex to mitochondria to protect the mitochondrial pore and function and a prolonged but more sustained phase that involves upregulation of ER␤ and phase II antioxidant genes such as HO-1 and GPx2. Our results suggest that the effects of 17␤-E 2 are ER␤ specific and open avenues for using selective ER␤ ligands for reducing oxidative stress, an important factor in the pathogenesis of AMD.
